Associated Papers
Impact of myelodysplasia-related gene mutations and residual mutations at remission in venetoclax/azacitidine for AML.
Ikoma Y et al.
Leukemia, 2025
40259101 (PubMed )
Supplement: 41375_2025_2625_MOESM2_ESM.xlsx › Sheet5
Clinical and molecular response to interferon-α therapy in essential thrombocythemia patients with CALR mutations.
Verger E et al.
Blood, 2015
Select a paper to view details